Metachromatic Leukodystrophy is an inherited disorder that is autosomal and recessive. It affects the fatty myelin sheath of neurons due to an enzyme deficiency. The main symptom of the disease is an inability to store lysosomes in the body. Currently, there are no treatment options or cures available for the disease. Management of the disease focuses on alleviating pain and symptoms. Stem cell therapy is providing a new path of research for a cure.
HOW IS METACHROMATIC LEUKODYSTROPHY DIAGNOSED?
Metachromatic Leukodystrophy (MLD) can be divided into three types depending on the age at which it affects an individual- Late Infantile MLD, Juvenile MLD and Adult MLD.